Orthofix Medical Inc.
- Last sale
- Nov 12, 2026 · -3.27%
- Market cap
- $283.08M
- 40.76M shares
- Filings
- 1,029
Q3 2026+2.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−1.5% FY25 yoy
- $283.08M
- —
- 0.3×
- 0.7×
- -15.71%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $822,312,000 | reported | |
| FY 2024 | 2024-12-31 | $799,491,000 | reported | |
| FY 2023 | 2023-12-31 | $746,641,000 | reported | |
| FY 2022 | 2022-12-31 | $460,713,000 | reported | |
| FY 2021 | 2021-12-31 | $464,479,000 | reported | |
| FY 2020 | 2020-12-31 | $406,562,000 | reported | |
| FY 2019 | 2019-12-31 | $459,955,000 | reported | |
| FY 2018 | 2018-12-31 | $453,042,000 | reported | |
| FY 2017 | 2017-12-31 | $433,823,000 | reported | |
| FY 2016 | 2016-12-31 | $409,788,000 | reported | |
| FY 2015 | 2015-12-31 | $396,489,000 | reported | |
| FY 2014 | 2014-12-31 | $402,277,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2016 | — | $63.43M | $63.43M | — | 17.95M sh | −2.3% | 148.7% |
| FY2015 | — | $11.58M | $11.58M | — | 18.37M sh | −2.1% | 70.5% |
| FY2013 | — | $39.49M | $39.49M | — | 18.75M sh | +3.1% | 93.5% |
| FY2009 | — | $220.00K | $220.00K | — | — | — | 0.7% |
Segments
LineFY2025ShareChange
Global Spine$687.66M84%+1.8%
Global Limb Reconstruction$134.66M16%+8.4%
Biologics———
Bone Growth Therapies———
Global Extremities———
Global Orthopedics———
Spinal Implants———
Total$822.31M
Surgical & medical instruments & apparatus
Orthofix Medical Inc. is the 23rd largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
EMBCEmbecta Corp.$1.1B3.8%8.8%$364.0MTNDMTandem Diabetes Care Inc$1.0B7.9%20.2%$1.2BINSPInspire Medical Systems, Inc.$912.0M13.6%15.9%$1.8B
OFIXOrthofix Medical Inc. (this company)$822.3M2.9%11.2%$283.1M
ATECAlphatec Holdings, Inc.$764.2M25.0%18.8%$1.1BIRTCiRhythm Holdings, Inc.$747.1M26.2%6.0%$4.2BNVCRNovoCure Ltd$655.4M8.3%20.8%$1.4BUFPTUFP Technologies Inc$602.8M19.5%11.3%$2.4BBVSBioventus Inc.$568.1M0.9%4.0%$916.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR